Neuro-oncology includes cancers of the brain and nervous system.

The Neuro-oncology Disease Site Group (Neuro-oncology Cancer DSG) produced evidence-based reports to assist practitioner and patient decisions about appropriate health care for specific clinical circumstances. Reports produced by this group are available below.

Malignant Glioma

  • Adjuvant Systemic Chemotherapy, Following Surgery and External Beam Radiotherapy, for Adults with Newly Diagnosed Malignant Glioma
    9-2 EBS: November 2006 Update
  • Radiotherapy for Newly Diagnosed Malignant Glioma in Adults
    9-3 EBS: November 2005 Update
  • Gliadel® Wafers in the Treatment of Malignant Glioma
    9-7 EBS: August 2006
  • Use of Temozolomide in the Treatment of Newly Diagnosed or Recurrent Malignant Glioma
    9-5 ES
    September 2005 : This document has been retired and is no longer available. Current recommendations for the use of temozolomide in newly-diagnosed malignant glioma are reflected in 9-2 EBS Adjuvant Systemic Chemotherapy, Following Surgery and External Beam Radiotherapy, for Adults with Newly Diagnosed Malignant Glioma and 9-3 EBS Radiotherapy for Newly Diagnosed Malignant Glioma in Adults.
  • Surgical Management of Malignant Glioma
    9-8 ES: July 2004

Other

Page Updated: 2008 Mar 31

Contact:
Program in Evidence-Based Care (PEBC)
McMaster University, Henderson Site
60 (G) Wing, 2nd Floor
711 Concession Street
Hamilton, Ontario, Canada
L8V 1C3

Phone: 905.527.4322 ext. 42822
Fax: 905.526.6775
Email: ccopgi@mcmaster.ca
Last modified: Fri, Feb 19, 2010

Cancer Care Ontario visitor survey

Please help improve the quality of our website by answering 9 brief questions in our online survey. Would you like to participate?

YesNo